WASHINGTON (Reuters) – The United States plans to invest billions of dollars in expanding COVID-19 vaccine manufacturing capacity and make available an additional one billion doses per year, White House COVID-19 coordinator Jeff Zients said on Wednesday.
کارکنوں نے صدر جو بائیڈن کی انتظامیہ پر غریب ممالک کو ویکسین کی فراہمی بڑھانے کے لیے دباؤ ڈالا ہے۔
زیئنٹس نے کہا کہ حکومت mRNA ویکسین بنانے والوں کو بنیادی ڈھانچے اور صلاحیت کو بڑھانے کے لیے خاطر خواہ مدد فراہم کرنے کی تیاری کر رہی ہے، بشمول سہولیات، آلات، عملہ یا تربیت۔
In the near future, the initiative would provide a sizable number of COVID-19 vaccination doses for cost for usage worldwide. Long-term, according to Zients, it would contribute in building up indigenous manufacturing capability to quickly create vaccinations against potential dangers.
According to Zients, 80% of Americans aged 12 and above have had at least one dosage of the COVID-19 vaccine, marking a significant advancement in the fight against the fatal virus’s spread.
Editing by Chizu Nomiyama, Bernadette Baum, and David Gregorio; reporting by Jeff Mason and Alexandra Alper; additional reporting by Doina Chiacu and Ahmed Aboulenein.
“The objective, in case of an impending a worldwide epidemic, a pandemic the virus, was to establish vaccine capacity within between six and nine months of detection of that epidemic infectious agent, and to provide sufficient vaccinations for all the Americans,” he said.
Also Read: US Considers $10bn Aid for Israel Amid Global Over Gaza attack
